vs

Side-by-side financial comparison of Ascendis Pharma A/S (ASND) and FTAI Infrastructure Inc. (FIP). Click either name above to swap in a different company.

Ascendis Pharma A/S is the larger business by last-quarter revenue ($267.3M vs $143.5M, roughly 1.9× FTAI Infrastructure Inc.). On growth, FTAI Infrastructure Inc. posted the faster year-over-year revenue change (77.7% vs 42.3%). Over the past eight quarters, Ascendis Pharma A/S's revenue compounded faster (60.7% CAGR vs 31.9%).

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.

ASND vs FIP — Head-to-Head

Bigger by revenue
ASND
ASND
1.9× larger
ASND
$267.3M
$143.5M
FIP
Growing faster (revenue YoY)
FIP
FIP
+35.4% gap
FIP
77.7%
42.3%
ASND
Faster 2-yr revenue CAGR
ASND
ASND
Annualised
ASND
60.7%
31.9%
FIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASND
ASND
FIP
FIP
Revenue
$267.3M
$143.5M
Net Profit
$-97.7M
Gross Margin
90.5%
Operating Margin
-45.7%
Net Margin
-68.1%
Revenue YoY
42.3%
77.7%
Net Profit YoY
21.6%
EPS (diluted)
$-1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASND
ASND
FIP
FIP
Q4 25
$267.3M
$143.5M
Q3 25
$230.7M
$140.6M
Q2 25
$170.7M
$122.3M
Q1 25
$109.0M
$96.2M
Q4 24
$187.8M
$80.8M
Q3 24
$62.5M
$83.3M
Q2 24
$38.9M
$84.9M
Q1 24
$103.6M
$82.5M
Net Profit
ASND
ASND
FIP
FIP
Q4 25
$-97.7M
Q3 25
$-65.9M
$-104.5M
Q2 25
$-42.0M
$-70.0M
Q1 25
$-102.2M
$120.2M
Q4 24
$-124.7M
Q3 24
$-107.1M
$-43.0M
Q2 24
$-118.1M
$-48.1M
Q1 24
$-141.5M
$-50.3M
Gross Margin
ASND
ASND
FIP
FIP
Q4 25
90.5%
Q3 25
89.5%
Q2 25
80.1%
Q1 25
82.6%
Q4 24
91.9%
Q3 24
80.6%
Q2 24
68.2%
Q1 24
92.1%
Operating Margin
ASND
ASND
FIP
FIP
Q4 25
-45.7%
Q3 25
5.1%
-70.8%
Q2 25
-33.5%
-56.4%
Q1 25
-103.2%
81.8%
Q4 24
-152.7%
Q3 24
-167.3%
-51.7%
Q2 24
-370.2%
-56.4%
Q1 24
-51.2%
-58.8%
Net Margin
ASND
ASND
FIP
FIP
Q4 25
-68.1%
Q3 25
-28.5%
-74.4%
Q2 25
-24.6%
-57.2%
Q1 25
-93.7%
125.0%
Q4 24
-154.4%
Q3 24
-171.5%
-51.6%
Q2 24
-303.9%
-56.7%
Q1 24
-136.6%
-60.9%
EPS (diluted)
ASND
ASND
FIP
FIP
Q4 25
$-1.04
Q3 25
$-1.38
Q2 25
$-0.73
Q1 25
$0.89
Q4 24
$-1.21
Q3 24
$-0.45
Q2 24
$-0.52
Q1 24
$-0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASND
ASND
FIP
FIP
Cash + ST InvestmentsLiquidity on hand
$665.3M
$57.4M
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$-175.8M
$21.3M
Total Assets
$1.4B
$5.7B
Debt / EquityLower = less leverage
176.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASND
ASND
FIP
FIP
Q4 25
$665.3M
$57.4M
Q3 25
$582.2M
$34.7M
Q2 25
$533.6M
$33.6M
Q1 25
$559.4M
$26.3M
Q4 24
$604.3M
$27.8M
Q3 24
$675.6M
$20.3M
Q2 24
$279.4M
$33.1M
Q1 24
$345.9M
$23.0M
Total Debt
ASND
ASND
FIP
FIP
Q4 25
$3.8B
Q3 25
$3.7B
Q2 25
$3.1B
Q1 25
$2.8B
Q4 24
$1.6B
Q3 24
$1.5B
Q2 24
$1.6B
Q1 24
$1.3B
Stockholders' Equity
ASND
ASND
FIP
FIP
Q4 25
$-175.8M
$21.3M
Q3 25
$-188.0M
$181.1M
Q2 25
$-202.6M
$375.5M
Q1 25
$-205.0M
$476.2M
Q4 24
$-114.2M
$202.7M
Q3 24
$-105.1M
$370.8M
Q2 24
$-346.8M
$394.8M
Q1 24
$-257.2M
$402.5M
Total Assets
ASND
ASND
FIP
FIP
Q4 25
$1.4B
$5.7B
Q3 25
$1.2B
$5.5B
Q2 25
$1.2B
$4.4B
Q1 25
$1.1B
$4.1B
Q4 24
$1.3B
$2.4B
Q3 24
$1.2B
$2.4B
Q2 24
$819.0M
$2.5B
Q1 24
$866.7M
$2.3B
Debt / Equity
ASND
ASND
FIP
FIP
Q4 25
176.99×
Q3 25
20.59×
Q2 25
8.21×
Q1 25
5.79×
Q4 24
7.84×
Q3 24
4.14×
Q2 24
3.94×
Q1 24
3.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASND
ASND
FIP
FIP
Operating Cash FlowLast quarter
$58.2M
$-2.8M
Free Cash FlowOCF − Capex
$-68.6M
FCF MarginFCF / Revenue
-47.8%
Capex IntensityCapex / Revenue
45.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-398.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASND
ASND
FIP
FIP
Q4 25
$58.2M
$-2.8M
Q3 25
$-24.4M
Q2 25
$-5.2M
Q1 25
$-15.5M
$-85.7M
Q4 24
$-330.7M
$-8.1M
Q3 24
$14.2M
Q2 24
$-17.6M
Q1 24
$-109.7M
$-3.9M
Free Cash Flow
ASND
ASND
FIP
FIP
Q4 25
$-68.6M
Q3 25
$-90.7M
Q2 25
$-87.5M
Q1 25
$-151.7M
Q4 24
$-34.3M
Q3 24
$-11.7M
Q2 24
$-32.1M
Q1 24
$-16.7M
FCF Margin
ASND
ASND
FIP
FIP
Q4 25
-47.8%
Q3 25
-64.5%
Q2 25
-71.6%
Q1 25
-157.7%
Q4 24
-42.4%
Q3 24
-14.0%
Q2 24
-37.9%
Q1 24
-20.3%
Capex Intensity
ASND
ASND
FIP
FIP
Q4 25
45.9%
Q3 25
47.2%
Q2 25
67.3%
Q1 25
68.6%
Q4 24
32.5%
Q3 24
31.1%
Q2 24
17.2%
Q1 24
15.6%
Cash Conversion
ASND
ASND
FIP
FIP
Q4 25
Q3 25
Q2 25
Q1 25
-0.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASND
ASND

Segment breakdown not available.

FIP
FIP

Power Revenues$45.9M32%
Rail Revenue$44.6M31%
Service Other$22.8M16%
Gas Revenues$15.3M11%
Roadside Services Revenues$11.5M8%
Rapauno$1.2M1%

Related Comparisons